No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full results8 funds hold a position.
No tracked top-trader positions in CHRN as of Oct 24, 09:32 UTC.
Hyperliquid positioning - not every stock is covered
Last report
Sep 28, 2026
Period ending
Aug 31, 2026
Earnings per share
-$0.06 expected
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Aug 31, 2026 | Sep 28, 2026 | -$1.24 / -$0.06Alpha Vantage | -$1.18 miss | $41.5M No estimateSEC filing | Unavailable |
| May 31, 2026 | Jul 27, 2026 | -$1.24 / -$0.06Alpha Vantage | -$1.18 miss | $71.6M No estimateYear ended May 31, 2026 · SEC filing | Unavailable |
| Mar 31, 2026 | Apr 28, 2026 | Unavailable | - | $2.1M No estimateSEC filing | Unavailable |
| Nov 30, 2025 | Feb 23, 2026 | Unavailable | - | Unavailable | Unavailable |
| Sep 30, 2025 | Oct 28, 2025 | Unavailable | - | $4.2M No estimateSEC filing | Unavailable |
| Aug 31, 2025 | Oct 29, 2025 | Unavailable | - | $16.7M No estimateSEC filing | Unavailable |
| Jun 30, 2025 | Jul 29, 2025 | Unavailable | - | $2.1M No estimateSEC filing | Unavailable |
| Mar 31, 2025 | Apr 28, 2026 | Unavailable | - | $3.4M No estimateSEC filing | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
This company is not yet profitable.
Valuation
Quality
Growth
This stock is under pressure.
Trend
Under pressure
25 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace